Related Experiment Video
Updated: Aug 12, 2025

Intravitreal Injection and Quantitation of Infection Parameters in a Mouse Model of Bacterial Endophthalmitis
Published on: February 6, 2021
Multiresistant Candida Endophthalmitis Treated with Intravitreal Caspofungin: A Case Report
Marta Garrido-Marin1, Eric Kirkegaard Biosca1, Anna Boixadera1
1Ophthalmology Department, Vall d'Hebron University Hospital, Barcelona, Spain.
Background:
Candida endophthalmitis is a severe complication of candidemia. Currently, the recommended treatment of fungal endophthalmitis is a combination of intravitreal and systemic antifungal drugs, and in some cases vitrectomy is also required. Intravitreal therapies that are commonly used are amphotericin B and voriconazole, although recently the use of intravitreal caspofungin has been described in a few case reports. However, clinical experience with intravitreal caspofungin is still limited.
Case Presentation:
We report a case of bilateral candida tropicalis endophthalmitis, initially managed with repeated 100 μg/0.1 ml caspofungin intravitreal injections and posteriorly treated with pars plana vitrectomy in both eyes.
Conclusions:
Intravitreal caspofungin could be a safe intravitreal alternative to habitual antimycotic drugs in cases with resistant candida endophthalmitis.Abbreviations: Intensive Care Unit (ICU); Best-Corrected Visual Acuity (BCVA).
Insights
Intravitreal caspofungin offers a potential alternative for treating resistant Candida endophthalmitis. This case study explores its use alongside vitrectomy for bilateral fungal eye infections.
Area of Science:
- Ophthalmology
- Mycology
- Infectious Diseases
Background:
- Candida endophthalmitis is a serious complication of candidemia.
- Standard treatment involves systemic and intravitreal antifungals, sometimes with vitrectomy.
- Intravitreal caspofungin use is emerging but clinical data remains limited.
Observation:
- A case of bilateral Candida tropicalis endophthalmitis is presented.
- Initial management included repeated intravitreal caspofungin injections (100 μg/0.1 ml).
- Subsequent treatment involved pars plana vitrectomy in both eyes.
Findings:
- Intravitreal caspofungin demonstrated potential as a treatment modality.
- The combination with vitrectomy was necessary for managing this severe bilateral case.
Implications:
- Intravitreal caspofungin may serve as a safe alternative for resistant fungal endophthalmitis.
- Further research is warranted to establish its efficacy and safety profile.
- This case contributes to the limited clinical experience with intravitreal caspofungin.
Related Concept Videos
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...
Angle Closure Glaucoma: Treatment
Endocarditis III: Medical Management

